Surveillance of barrett's columnar-lined oesophagus in the UK: Endoscopic intervals and frequency of detection of dysplasia

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 6, 2009, Pages 636-641

  Ramus, James R ^a,b   Gatenby, Piers A C ^a   Caygill, Christine R J ^a   Winslet, Marc C ^a   Watson, Anthony ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Tree House   (United Kingdom)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Dysplasia; Endoscopy; Surveillance

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BARRETT COLUMNAR LINED ESOPHAGUS; BARRETT ESOPHAGUS; COHORT ANALYSIS; COLUMNAR EPITHELIUM; DISEASE ASSOCIATION; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; UNITED KINGDOM;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; DISEASE PROGRESSION; EARLY DIAGNOSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; PROFESSIONAL PRACTICE; REGISTRIES; TIME FACTORS;

EID: 67649664089     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32832183bc     Document Type: Article

References (32)

1. Bartlesman JF, Hameeteman W, Tytgat GN. Barrett's oesophagus. Eur J Cancer Prev 1992; 1:323-325.
2. Solaymani-Dodaran M, Coupland C, Logan R. Risk of oesophageal cancer in Barrett's oesophagus and in gastro-oesophageal reflux. Gut 2003; 52:[A20].
3. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96 (5 Pt 1):1249-1256.
4. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988; 75:760-763.
5. Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984; 87:927-933.
6. Ovaska J, Miettinen M, Kivilaakso E. Adenocarcinoma arising in Barrett's esophagus. Dig Dis Sci 1989; 34:1336-1339.
7. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119:p333-p338.
8. Gatenby PAC, Caygill CPJ, Ramus JR, Charlett A, Watson A. Barrett's columnar-lined oesophagus: demographics and lifestyle associations and adenocarcinoma risk. Dig Dis Sci 2008; 53:1175-1185.
9. Menke-Pluymers MB, Schoute NW, Mulder AH, Hop WC, Van Blankenstein M, Tilanus HW. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gum992; 33:1454-1458.
10. DeMeester TR, Attwood SE, Smyrk TC, Therkildsen DH, Hinder RA. Surgical therapy in Barrett's esophagus. Ann Surg 1990; 212:528-540.
11. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216:583-590.
12. Fitzgerald RC, Saeed IT, Khoo D, Farthing MJ, Burnham WR. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Dig Dis Sci 2001; 46:1892-1898.
13. Van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Guf 1998; 43:216-222.
14. Fountoulakis A, Zafirellis KD, Dolan K, Dexter SP, Martin IG, Sue-Ling HM. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 2004; 91:997-1003.
15. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000; 321:1252-1255.
16. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol 1988; 83:291-294.
17. Gross CP, Canto Ml, Hixson J, Powe NR. Management of Barrett's esophagus: a national study of practice patterns and their cost implications. Am J Gastroenterol 1999; 94:3440-3447.
18. Smith AM, Maxwell-Armstrong CA, Welch NT, Scholefield JH. Surveillance for Barrett's oesophagus in the UK. Br J Surg 1999; 86:276-280.
19. Mandal A, Playford RJ, Wicks AC. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol Ther 2003; 17:1319-1324.
20. Ramus JR, Caygill CPJ, Gatenby PAC, Watson A. Current United Kingdom practice in the diagnosis and management of columnar-lined oesophagus: results of the United Kingdom National Barrett's Oesophagus Registry endoscopist questionnaire. Eur J Cane Prev 2008; 17:422-425.
21. Edwards MJ, Gable DR, Lentsch AB, Richardson JB. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia Ann Surg 1996; 223:585-589.
22. Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108:813-822.
23. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996; 224:66-71.
24. Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993; 88:1832-1836.
25. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120:1607-1619.
26. SPSS for windows. (11.0). 2001.
27. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994; 89:670-680.
28. The World Congress of Gastroenterology. Sydney: World Gastroenterology Organization; 1990.
29. Watson A, Heading RC, Shepherd NA. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. A report of the working party of the British Society of Gastroenterology 2005.
30. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97:1888-1895.
31. Pech O, Behrens A, May A, Nachbar L, Gossner l- Rabenstein T, et al. Long- term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008; 57:1200-1206.
32. Ganapathy AP, Wang KK, Buttar NS, Wongkeesong L, Krishnadath KK, Nichols FC III, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007; 132:1226-1233.